Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 appears in the Study Record Versions, indicating the latest update to the record history. This reflects administrative versioning rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-22T02:27:55.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the Record History, replacing the previous v3.6.5, signaling a software update to the page.
    Difference
    0.1%
    Check dated 2026-08-31T23:29:11.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    A new revision label v3.6.5 was added to the record history and the previous v3.6.4 label was removed, updating the revision trail for the study record.
    Difference
    0.1%
    Check dated 2026-08-10T12:45:13.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.4 was added to the record history, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-27T06:24:53.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.3 was added to the Record History, reflecting a site update to the ClinicalTrials.gov page. This update documents the latest version of the page without changing the study details.
    Difference
    0.1%
    Check dated 2026-07-05T14:24:15.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a small update to the study record presentation.
    Difference
    0.1%
    Check dated 2026-06-28T08:33:46.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.